Continuing issues and debate concerning transnational commercial surrogacy during the COVID-19 pandemic and beyond
By Yuri Hibino, Sonia Allan, and Damian Adams,
BioNews
| 11. 30. 2020
The regulation of surrogacy varies around the world. Most countries that have laws, prohibit all forms of surrogacy, while several permit altruistic arrangements. A small number permit commercial surrogacy arrangements, and accept commissioning couples, or singles from nations where prohibitions exist. As a result, issues abound. For example, despite growing recognition that children have a right to information about their birth mother, gamete donor(s), and genetic siblings, transnational arrangements may provide little to no opportunity to build relationships when separated by language, culture, and/or location. Issues regarding the sale and commodification of children persist; cases of child abandonment are known. Trafficking of women across borders, bonded labour, health risks associated with surrogacy and egg donation, and ill-treatment of surrogates and intending mothers reported.
In 2020, COVID-19 also saw up to 1000 babies left in hospitals (or orphanages) in Russia, with intending parents unable to travel. In the Ukraine, babies were cared for in hotel rooms by nurses or nannies, or placed into public care (see BioNews 1048). Some surrogates struggled as they bonded with the baby or worried...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...